Molecular testing for Chlamydia trachomatis and Neisseria gonorrhoeae

Alexandra Valsamakis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Chlamydia trachomatis and Neisseria gonorrhoeae are currently the two most prevalent pathogens in the United States. The costs of infections, to individuals and society, are significant. Unfortunately, these pathogens can be difficult to detect with conventional diagnostic methods. New molecular techniques have improved diagnosis and have made screening possible. This aim of this chapter is to provide practical information on molecular testing for C. trachomatis and N. gonorrhoeae that is useful to practitioners of molecular pathology. Introductory information on the clinical significance and conventional diagnostic tests is provided. Issues confronting molecular testing for these pathogens are discussed. Descriptions of each molecular platform are provided, including performance characteristics and other parameters of functionality.

Original languageEnglish (US)
Title of host publicationMolecular Diagnostics
Subtitle of host publicationFor the Clinical Laboratorian
PublisherHumana Press
Pages437-445
Number of pages9
ISBN (Print)9781588293565
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Molecular testing for Chlamydia trachomatis and Neisseria gonorrhoeae'. Together they form a unique fingerprint.

Cite this